profit from every $100 of sales.
$0$100
Align Technology
$172.08-1.25% today
+19.1% in 1 year
1-year low $132.281-year high $197.51
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2020 to 2025.
0%20% a year
You pay $29.56 for every $1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Align Technology sold, what it kept, and what it did with the cash.
Sales went from $3.73 billion in 2022 to $4.03 billion in 2025, with $410 million of profit last year.
SalesProfit
Align Technology handed back 95% of the cash it generated last year.
Buybacks $466M
Free cash flow 2025$491M
Bought back its own shares$466M
Paid as dividends–
Cash vs. debt$1.1B vs. $114M
Align Technology vs. similar companies
Align Technology grows in the middle of these 5 and is priced in the middle for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Align Technology | 29.6× · Fair price | ||
 Boston Scientific | 22.6× · Fair price | ||
 Koninklijke Philips | 29.7× · Fair price | ||
 Steris | 31.8× · Expensive | ||
 Zimmer Biomet Holdings | 28.8× · Fair price |
AI analysis
An AI analyst reads Align Technology's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 2,472 | 3,953 | 3,735 | 3,862 | 3,999 | 4,035 | |
| 1,763 | 2,935 | 2,634 | 2,707 | 2,799 | 2,711 | |
| – | – | 654 | 657 | 672 | 585 | |
| – | – | 780 | 799 | 817 | 823 | |
| 1,776 | 772 | 362 | 445 | 421 | 410 | |
| 22.41 | 9.69 | 4.61 | 5.81 | 5.62 | 5.65 | |
| 71.3% | 74.3% | 70.5% | 70.1% | 70.0% | 67.2% | |
| – | – | 17.5% | 17.0% | 16.8% | 14.5% | |
| 71.8% | 19.5% | 9.7% | 11.5% | 10.5% | 10.2% |
Balance sheet
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 4,830 | 5,942 | 5,948 | 6,084 | 6,215 | 6,234 |
| Cash | 961 | 1,099 | 942 | 937 | 1,044 | 1,095 |
| Total debt | – | – | 127 | 127 | 119 | 114 |
| Total liabilities | 1,596 | 2,319 | 2,347 | 2,453 | 2,363 | 2,185 |
| 3,234 | 3,623 | 3,601 | 3,630 | 3,852 | 4,049 | |
| 79 | 80 | 78 | 77 | 75 | 73 | |
| – | – | 13.9% | 13.8% | 13.4% | 11.1% | |
| 54.9% | 21.3% | 10.0% | 12.3% | 10.9% | 10.1% |
Cash flow
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 662 | 1,173 | 569 | 786 | 738 | 593 | |
| 155 | 401 | 292 | 178 | 116 | 102 | |
| 507 | 771 | 277 | 608 | 623 | 491 | |
| Dividends paid | – | – | – | – | – | – |
| 0 | 375 | 435 | 592 | 353 | 466 | |
| 98 | 114 | 133 | 154 | 174 | 186 |
Valuation
- 29.6×
- 15.2×
- –
- 2.8×
- 3.0×
- 24.7×
- 13.6×
- 4.0%
- 3.4%
- 0.0%
Profitability
- 67.2%
- 14.5%
- 10.2%
- 19.7%
- 9.7%
- 12.5%
- 10.7%
- 6.8%
- 13.4%
- 9.1%
Growth
- +10.3%
- −24.1%
- −21.2%
- –
- −2.1%
Financial health
- -1.2×
- 0.02
- 1.3%
- 378.3×
- 1.39
- 1.28
- 0.65
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 31%of 958
Top 36%of 889
Bottom 45%of 601
Bottom 48%of 890
Top 28%of 987
What analysts expect
- Average price target
- $203.60
- Range
- $185.00 – $235.00
- 4 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 29, 2026 | 2.58 | 2.26 | +14.2% |
| Feb 4, 2026 | 3.29 | 2.99 | +10.0% |
| Oct 29, 2025 | 2.61 | 2.40 | +8.8% |
| Jul 30, 2025 | 2.49 | 2.57 | −3.1% |
| Apr 30, 2025 | 2.13 | 1.99 | +7.0% |
| Feb 5, 2025 | 2.44 | 2.43 | +0.4% |
| Oct 23, 2024 | 2.35 | 2.31 | +1.7% |
| Jul 24, 2024 | 2.41 | 2.34 | +3.0% |
News
Align Technology says European court finds Angelalign infringed patentSeeking Alpha · Oct 18, 2026Lucid's Q3 deliveries fall 6.7% as EV maker cuts production to align with demandCNBC · Oct 5, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
63Pass
Benjamin Graham
47No pass
Philip Fisher
56No pass
Peter Lynch
34No pass
Joel Greenblatt
26No pass
Charlie Munger
54No pass
Terry Smith
51No pass
Questions about Align Technology
Is Align Technology a good stock to buy?
A solid business at a fair price. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Align Technology AI analysis
What does Align Technology do?
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It is in Medical - Devices, based in Tempe, AZ, United States, with 20,275 employees.
Does Align Technology pay a dividend?
No. Align Technology does not pay a dividend at the moment; in 2025 it returned $466 million to shareholders by buying back its own shares.
Is Align Technology stock halal?
Yes. Align Technology passes our halal screen: its business is permitted and its debt is 0.9% of its market value, under the 30% limit. How we check
How has Align Technology stock done over the past year?
Up 19.1% over the past twelve months, to $172.08. It traded between $132.28 and $197.51 and is 12.9% below its high.
Who are Align Technology's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with Align Technology's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.